Efficacy based on tumor PD-L1 expression in KEYNOTE-002, a randomized comparison of pembrolizumab (p - 论文文献免费下载 - 皮皮文库

Efficacy based on tumor PD-L1 expression in KEYNOTE-002, a randomized comparison of pembrolizumab (p

来源 :2015年临床肿瘤学新进展学术研讨会 | 被引量 : 0次 | 上传用户：dragonpxm

【作者】

：

Igor Puzanov Reinhard Dummer Jacob Schachter Anna C. Pavlick Rene Gonzalez Paolo Antonio Ascierto Kim Allyson Margolin Omid Hamid Sanjiv S. Agarwala Matteo S. Carlino Jochen Utikal Michal Lotem Antoni

【机构】

：

Vanderbilt University Medical Center, Nashville, TN

【出处】

：

2015年临床肿瘤学新进展学术研讨会

【发表日期】

：

2015年3期

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

A phase Ⅱ/Ⅲ, double-blind, randomized trial comparing maintenance lapatinib versus placebo after fir

会议

Phase Ⅲ trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachex

会议

Long-term safety of fertility preservation by ovarian stimulation and concurrent aromatase inhibitor

会议

Chemotherapy-related cognitive impairment (CRCI), and neurotransmitter signaling, longevity, and inf

会议

CALGB 70604 (Alliance): A randomized phase Ⅲ study of standard dosing vs. longer interval dosing of

会议

Successful implementation of a novel trial model: The Signature program.

会议

A pharmacokinetically (PK) and pharmacodynamically (PD) driven phase I trial of the pan-AKT inhibito

会议

A phase I study of PF-05082566 (anti-4-1BB) + rituximab in patients with CD20+ NHL

会议

Phase Ⅱ multicenter proof of concept study of AZD4547 in FGFR amplified tumours

会议

Safety and efficacy of MEDI4736, an anti-PD-L1 antibody, in patients from a squamous cell carcinoma

会议

其他学术论文